Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Greenwood

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Demographic Economics|November 17, 2018
MEASUREMENT WITHOUT THEORY, ONCE AGAINJeremy Greenwood, Ananth Seshadri, Guillaume Vandenbroucke
The American Economic Review|March 20, 2018
The Role of Marriage in Fighting HIV: A Quantitative Illustration for MalawiJeremy Greenwood, Philipp Kircher, Cezar Santos, et al.
Pain|January 7, 2017
A novel inhibitor of active protein kinase G attenuates chronic inflammatory and osteoarthritic painYing-Ju Sung, Nelson Sofoluke, Mary Nkamany, et al.
Current Opinion in Structural Biology|November 7, 2016
Accelerating drug discovery through tight integration of expert molecular design and predictive scoringRobert Abel, Sayan Mondal, Craig Masse, et al.
Journal of Medicinal Chemistry|February 14, 2008
Structures of the ligand-binding core of iGluR2 in complex with the agonists (R)- and (S)-2-amino-3-(4-hydroxy-1,2,5-thiadiazol-3-yl)propionic acid explain their unusual equipotencyMads Beich-Frandsen, Darryl S Pickering, Osman Mirza, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2016
Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in ratsGeraldine Harriman, Jeremy Greenwood, Sathesh Bhat, et al.
Nature Medicine|September 20, 2016
Inhibition of acetyl-CoA carboxylase suppresses fatty acid synthesis and tumor growth of non-small-cell lung cancer in preclinical modelsRobert U Svensson, Seth J Parker, Lillian J Eichner, et al.
Journal of the American Chemical Society|January 28, 2015
Accurate and reliable prediction of relative ligand binding potency in prospective drug discovery by way of a modern free-energy calculation protocol and force fieldLingle Wang, Yujie Wu, Yuqing Deng, et al.
Journal of Medicinal Chemistry|July 10, 2023
Discovery of a Potent and Selective Tyrosine Kinase 2 Inhibitor: TAK-279Silvana Leit, Jeremy Greenwood, Samantha Carriero, et al.
Cell Metabolism|September 25, 2018
Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular CarcinomaJames S V Lally, Sarani Ghoshal, Danielle K DePeralta, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Demographic Economics|November 17, 2018
MEASUREMENT WITHOUT THEORY, ONCE AGAINJeremy Greenwood, Ananth Seshadri, Guillaume Vandenbroucke
The American Economic Review|March 20, 2018
The Role of Marriage in Fighting HIV: A Quantitative Illustration for MalawiJeremy Greenwood, Philipp Kircher, Cezar Santos, et al.
Pain|January 7, 2017
A novel inhibitor of active protein kinase G attenuates chronic inflammatory and osteoarthritic painYing-Ju Sung, Nelson Sofoluke, Mary Nkamany, et al.
Current Opinion in Structural Biology|November 7, 2016
Accelerating drug discovery through tight integration of expert molecular design and predictive scoringRobert Abel, Sayan Mondal, Craig Masse, et al.
Journal of Medicinal Chemistry|February 14, 2008
Structures of the ligand-binding core of iGluR2 in complex with the agonists (R)- and (S)-2-amino-3-(4-hydroxy-1,2,5-thiadiazol-3-yl)propionic acid explain their unusual equipotencyMads Beich-Frandsen, Darryl S Pickering, Osman Mirza, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2016
Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in ratsGeraldine Harriman, Jeremy Greenwood, Sathesh Bhat, et al.
Nature Medicine|September 20, 2016
Inhibition of acetyl-CoA carboxylase suppresses fatty acid synthesis and tumor growth of non-small-cell lung cancer in preclinical modelsRobert U Svensson, Seth J Parker, Lillian J Eichner, et al.
Journal of the American Chemical Society|January 28, 2015
Accurate and reliable prediction of relative ligand binding potency in prospective drug discovery by way of a modern free-energy calculation protocol and force fieldLingle Wang, Yujie Wu, Yuqing Deng, et al.
Journal of Medicinal Chemistry|July 10, 2023
Discovery of a Potent and Selective Tyrosine Kinase 2 Inhibitor: TAK-279Silvana Leit, Jeremy Greenwood, Samantha Carriero, et al.
Cell Metabolism|September 25, 2018
Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular CarcinomaJames S V Lally, Sarani Ghoshal, Danielle K DePeralta, et al.
Pageof 1